Skip to main content
Indietro

Exam 3 Study Guide: Infectious Disease, Host-Microbe Interactions, Biomedical Applications, Antimicrobial Drugs, Respiratory, Skin, and Eye Infections

Guida di studio - Note intelligenti

Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.

Principles of Infectious Disease

Categories of Pathogenic Organisms and Vectors

  • Pathogens include bacteria, viruses, fungi, protozoa, and helminths.

  • Vectors are living organisms (often arthropods like mosquitoes or ticks) that transmit pathogens between hosts.

Infectious Disease Vocabulary

  • Pathogenicity: The ability of a microbe to cause disease.

  • Virulence: The degree of pathogenicity within a group or species.

  • Reservoir: The natural habitat of a pathogen.

  • Carrier: An individual who harbors a pathogen without showing symptoms.

Koch’s Postulates

  • Set of criteria to establish a causative relationship between a microbe and a disease:

    1. The microorganism must be found in all organisms suffering from the disease, but not in healthy organisms.

    2. The microorganism must be isolated from a diseased organism and grown in pure culture.

    3. The cultured microorganism should cause disease when introduced into a healthy organism.

    4. The microorganism must be re-isolated from the inoculated, diseased experimental host and identified as being identical to the original specific causative agent.

  • Limitations: Some pathogens cannot be cultured, some diseases are caused by multiple organisms, and ethical issues may prevent experimentation.

Modes of Transmission

  • Direct transmission: Physical contact, droplets, vertical (mother to child).

  • Indirect transmission: Fomites, vectors, contaminated food/water.

Five Stages of Infection

  • Incubation period

  • Prodromal phase

  • Acute phase

  • Period of decline

  • Convalescent phase

Epidemiology

  • Definition: Study of the distribution and determinants of health-related states in populations.

  • Goals: Identify causes, patterns, and control of diseases.

  • Epidemiological triangle: Agent, host, environment.

  • Breaking the triangle: Remove one component to stop disease spread (e.g., vaccination, sanitation).

Conditions Necessary for Disease

  • Susceptible host

  • Pathogen with sufficient virulence

  • Proper environment for transmission

Measures of Frequency and Association

  • Incidence: Number of new cases in a population over a period.

  • Prevalence: Total number of cases at a given time.

  • Relative risk (RR) and odds ratio (OR) measure association between exposure and disease.

Descriptive vs. Analytical Epidemiological Studies

  • Descriptive: Characterize distribution of disease (who, where, when).

  • Analytical: Investigate causes and risk factors (how, why).

Healthcare-Associated Infections (HAIs)

  • Transmission: Direct contact, contaminated equipment, airborne.

  • Prevention: Hand hygiene, sterilization, isolation protocols.

Surveillance Programs

  • Purpose: Monitor and control disease spread.

  • Classifications: Passive, active, sentinel, syndromic.

  • Ethics: Protect privacy, informed consent.

Host-Microbe Interactions

Types of Host-Microbe Interactions

  • Mutualism: Both host and microbe benefit.

  • Commensalism: Microbe benefits, host unaffected.

  • Parasitism: Microbe benefits, host is harmed.

Opportunistic Pathogens

  • Cause disease in immunocompromised hosts or when introduced to unusual sites.

Tropism and Host Range

  • Tropism: Preference of a pathogen for a specific host tissue.

  • Host range: Spectrum of hosts a pathogen can infect.

Virulence and Mechanisms

  • Virulence: Degree of pathogenicity.

  • Mechanisms: Toxins, adhesion factors, immune evasion.

R Numbers, ID, and LD Values

  • R number (R0): Average number of secondary cases from one infected individual.

  • ID50: Infectious dose for 50% of population.

  • LD50: Lethal dose for 50% of population.

Endotoxins and Exotoxins

  • Endotoxins: Lipopolysaccharide (LPS) from Gram-negative bacteria; released on cell death.

  • Exotoxins: Proteins secreted by bacteria; diverse mechanisms (e.g., neurotoxins, enterotoxins).

Biosafety Levels (BSL)

  • BSL-1: Non-pathogenic microbes; minimal precautions.

  • BSL-2: Moderate risk; lab coats, gloves.

  • BSL-3: Aerosol transmission; controlled access, biosafety cabinets.

  • BSL-4: High risk, life-threatening; full-body suits, specialized facilities.

Biomedical Applications

Vaccine History and Types

  • History: Edward Jenner (smallpox), Louis Pasteur (rabies), Jonas Salk (polio).

  • Types: Live attenuated, inactivated, subunit, toxoid, conjugate, mRNA, viral vector.

  • Applications: Prevent infectious diseases, control outbreaks.

Immunologic Tests

  • Purpose: Detect antigens or antibodies.

  • Protocols: ELISA, agglutination, immunofluorescence.

  • Applications: Diagnosis, blood typing, monitoring immunity.

Genetic Manipulations

  • Genetic engineering: Creating recombinant plasmids and cells for research or therapy.

  • PCR and RT-PCR: Amplify DNA/RNA for detection and analysis.

  • CRISPR-Cas9: Genome editing tool for targeted modifications.

  • Gene therapy: Treating diseases by correcting defective genes.

  • Genome mapping and microarrays: Analyze gene expression and genetic variation.

Antimicrobial Drugs

Classifications and Relationships

  • Classified by target (cell wall, protein synthesis, nucleic acid synthesis, etc.) and spectrum (broad vs. narrow).

Key Definitions

  • Broad spectrum: Effective against many organisms.

  • Narrow spectrum: Effective against specific organisms.

  • -static vs. -cidal: Inhibit growth vs. kill microbes.

  • Therapeutic index: Ratio of toxic dose to therapeutic dose.

  • Selective toxicity: Drug harms pathogen, not host.

Major Antibiotic Classes

Class

Structure

Mechanism

Spectrum/Target

Examples

Side Effects

Penicillins

Beta-lactam ring

Inhibit cell wall synthesis

Gram-positive, some Gram-negative

Penicillin G, amoxicillin

Allergy, GI upset

Glycopeptides

Large peptide

Inhibit cell wall synthesis

Gram-positive

Vancomycin

Nephrotoxicity

Quinolones

Quinoline core

Inhibit DNA gyrase

Broad

Ciprofloxacin

Tendon rupture

Macrolides

Macrocyclic lactone

Inhibit protein synthesis

Gram-positive, some Gram-negative

Erythromycin

GI upset

Polypeptides

Peptide chain

Disrupt cell membrane

Gram-negative

Polymyxin B

Neurotoxicity

Antivirals, Antifungals, Antiprotozoals, Antihelminths

  • Antivirals: Inhibit viral entry, replication, or release (e.g., acyclovir, oseltamivir).

  • Antifungals: Target ergosterol or cell wall (e.g., amphotericin B, fluconazole).

  • Antiprotozoals: Inhibit nucleic acid or protein synthesis (e.g., metronidazole).

  • Antihelminths: Disrupt metabolism or neuromuscular function (e.g., mebendazole).

Assessing Antimicrobial Sensitivity

  • Kirby-Bauer test: Disk diffusion assay for susceptibility.

  • E-test: Gradient strip for MIC determination.

  • Broth dilution: Determines MIC and MBC (minimum bactericidal concentration).

Drug Resistance

  • Acquisition: Mutation, horizontal gene transfer.

  • Mechanisms: Enzyme inactivation, target modification, efflux pumps.

  • Prevention: Appropriate use, combination therapy, infection control.

Drug Development

  • Steps: Discovery, preclinical testing, clinical trials, approval.

  • Obstacles: Cost, resistance, toxicity, regulatory hurdles.

Respiratory System Infections

Structure and Function

  • Upper and lower respiratory tracts; functions in gas exchange and defense.

Normal Microbiota

  • Located in upper tract; includes Streptococcus, Staphylococcus, Corynebacterium.

Allergies vs. Infections

  • Allergies: Immune response to non-pathogenic antigens; symptoms include sneezing, itching; treated with antihistamines.

  • Infections: Caused by pathogens; symptoms include fever, pus; treated with antimicrobials.

Viral Respiratory Infections

Disease

Causative Agent

Transmission

Symptoms

Diagnosis

Prevention/Treatment

Colds

Rhinoviruses

Droplets, contact

Sneezing, runny nose

Clinical

Supportive care

Influenza

Influenza virus

Droplets

Fever, cough

Rapid antigen test

Vaccination, antivirals

COVID-19

SARS-CoV-2

Droplets, aerosols

Fever, cough, loss of taste

PCR

Vaccination, supportive

Hantavirus

Hantavirus

Rodent excreta

Fever, respiratory distress

Serology

Supportive

Bacterial Respiratory Infections

  • Otitis media: Streptococcus pneumoniae, Haemophilus influenzae; ear pain, fever; diagnosed clinically; treated with antibiotics.

  • Streptococcal pharyngitis: Streptococcus pyogenes; sore throat, fever; rapid strep test; antibiotics.

  • Diphtheria: Corynebacterium diphtheriae; pseudomembrane, sore throat; culture; antitoxin, antibiotics.

  • Pertussis: Bordetella pertussis; whooping cough; PCR; antibiotics, vaccination.

  • Tuberculosis: Mycobacterium tuberculosis; chronic cough, weight loss; sputum test; multi-drug therapy.

  • Bacterial pneumonias: Streptococcus pneumoniae, Klebsiella pneumoniae; cough, fever; chest X-ray; antibiotics.

Fungal Respiratory Infections

  • Blastomycosis: Blastomyces dermatitidis; inhalation; fever, cough; culture; antifungals.

  • Coccidiomycosis: Coccidioides immitis; inhalation; chest pain; serology; antifungals.

  • Histoplasmosis: Histoplasma capsulatum; inhalation; flu-like; antigen test; antifungals.

  • Pneumocystis pneumonia: Pneumocystis jirovecii; immunocompromised; cough, hypoxia; microscopy; TMP-SMX.

  • Mucormycosis: Mucor spp.; inhalation; necrosis; biopsy; antifungals.

  • Aspergillosis: Aspergillus spp.; inhalation; hemoptysis; imaging; antifungals.

Skin and Eye Infections

Structure and Function of Skin

  • Skin: Epidermis, dermis, subcutaneous layers; barrier and immune functions.

Viral Skin Infections

Disease

Causative Agent

Transmission

Symptoms

Diagnosis

Prevention/Treatment

Varicella-zoster

Varicella-zoster virus

Airborne, contact

Rash, fever

Clinical

Vaccine, antivirals

Smallpox

Variola virus

Airborne

Pustular rash

Clinical

Vaccine (eradicated)

Herpes simplex 1

HSV-1

Contact

Cold sores

Clinical, PCR

Antivirals

Measles

Measles virus

Airborne

Rash, Koplik spots

Serology

Vaccine

Rubella

Rubella virus

Airborne

Rash, fever

Serology

Vaccine

HPVs (warts)

Human papillomavirus

Contact

Warts

Clinical

Cryotherapy, vaccine

Bacterial Skin Infections

  • Acne: Cutibacterium acnes; blocked follicles; topical/oral antibiotics.

  • Staphylococcus aureus diseases: Impetigo, cellulitis, abscesses; contact; antibiotics.

  • Streptococcus pyogenes diseases: Erysipelas, necrotizing fasciitis; contact; antibiotics.

  • Pseudomonas aeruginosa diseases: Wound infections, especially burns; antibiotics.

  • Gangrene: Clostridium perfringens; trauma; debridement, antibiotics.

  • Cutaneous anthrax: Bacillus anthracis; spores; antibiotics.

Fungal Skin Infections

  • Mycoses: General term for fungal infections.

  • Candidiasis: Candida albicans; moist areas; antifungals.

  • Dermatophytic infections: Trichophyton, Microsporum; ringworm; topical/oral antifungals.

Parasitic Skin Infections

  • Leishmaniasis: Leishmania spp.; sandfly vector; cutaneous, mucocutaneous, visceral forms; antiprotozoals.

Eye Structure, Function, and Diseases

  • Structures: Cornea, conjunctiva, sclera, retina.

  • Functions: Vision, protection.

  • Diseases: Conjunctivitis, keratitis, endophthalmitis; caused by bacteria, viruses, fungi, or parasites.

  • Defenses: Tears (lysozyme), blinking, immune cells.

Additional info: Where details were not specified, standard textbook knowledge was used to fill in mechanisms, examples, and protocols.

Pearson Logo

Study Prep